[ad_1] With an estimated $8 billion opportunity in the coming years, India is well-positioned to expand its global footprint in the CDMO sector. However, capturing a larger market share will require substantial infrastructure, talent, and compliance investments. In this special edition of Market Master, Madhu Kela, Founder of MK Ventures, discusses India’s CDMO potential with […]
Pharma exports gain momentum in fourth quarter, CDMO players lead growth – CNBC TV18
[ad_1] The exports of the Indian pharmaceutical sector have witnessed a solid performance in the January to March quarter (Q4) of the 2024-25 fiscal year (FY25), with Contract Development and Manufacturing Organisations (CDMO) emerging as key growth drivers. According to Phillip Capital, the latest export data highlights robust momentum, particularly for companies engaged in producing […]
Invesco MF’s Taher Badshah sees government support as key to driving consumption – CNBC TV18
[ad_1] Taher Badshah, Chief Investment Officer of Invesco Mutual Fund stressed the importance of reviving domestic growth. He believes that the government should take strong measures to support the economy at this stage. Sectors like automobiles need a boost in domestic growth, he said, adding that “We might probably need that for some more time […]
Sensex Today | Stock Market LIVE Updates: Nifty hinges on Budget announcements for further recovery amid Trump tariffs
[ad_1] Sensex Today | Stock Market LIVE: The stock exchanges are open today, February 1, for a special trade session as the Finance Minister Nirmala Sitharaman will table the Union Budget 2025 in Parliament today. Sensex Today | Stock Market LIVE: Indian benchmark indices Nifty 50 and Sensex ended the previous trade session higher. Nifty […]
Elara Securities expects earnings upgrades for these pharma stocks – CNBC TV18
[ad_1] Bino Pathiparampil, Head of Research at Elara Securities (India), listed the brokerage’s top picks from the pharma sectors that are expected to benefit the most from a falling rupee. “The depreciation in rupee is going to help almost all the players, especially the large players who have big presences in the US. So that […]
Rahul Chadha recommends buying the market on dips, favours large caps – CNBC TV18
[ad_1] Rahul Chadha, Founder and Chief Investment Officer (CIO) of Shikhara Investment Management believes the market presents a good opportunity to buy on dips over the next three to six months. “We are going out and telling our investors that next three to six months give you an opportunity. For India, specifically, large caps become […]
India’s pharma and meditech industry set to double by 2030: Pharma Secretary – CNBC TV18
[ad_1] India’s pharmaceutical and meditech industry, valued at approximately $70 billion, is on track to nearly double by 2030, according to Arunish Chawla, Secretary of the Department of Pharmaceuticals. In an interview with CNBC-TV18, Chawla highlighted that this growth is driven by India’s expanding CRDMO (Contract Research Development Manufacturing Organisation) ecosystem, which is developing rapidly […]
Explainer | Not standard quality vs Spurious Drugs — What you need to know – CNBC TV18
[ad_1] The Central Drugs Standards Control Organisation (CDSCO) has recently released a list identifying 53 drugs as Not Standard Quality (NSQ), which has raised significant concern within the pharmaceutical industry. The list includes essential medications from reputable companies like Alchem, Sun Pharma, and Glenmark, highlighting a pressing issue regarding drug quality in India. However, these […]
DSP Mutual Fund eyes auto ancillary companies catering to both ICE and electric vehicles – CNBC TV18
[ad_1] DSP Mutual Fund is looking at players in the auto ancillary space which are serving both internal combustion engine (ICE) and electric vehicle (EV) space to add in its active portfolio. Vinit Sambre, Head of Equities at DSP Mutual Fund, in an interview, explained how keenly they watch these companies. “That is how we would […]